Overview

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

Status:
Active, not recruiting

Trial end date:
2022-07-16

Target enrollment:

Participant gender:

Summary

To determine the effectiveness of patient controlled methylphenidate as compared to placebo for the management of cancer related fatigue as determined by the Functional Assessment of Chronic Illness Therapy (FACIT)-F Fatigue score.

Phase:

Phase 3

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Methylphenidate